48,460
edits
Difference between revisions of "Clear cells in the kidney"
Jump to navigation
Jump to search
no edit summary
(+ref) |
|||
| (2 intermediate revisions by the same user not shown) | |||
| Line 9: | Line 9: | ||
*[[Clear cell papillary renal cell tumour]] (previously [[clear cell papillary renal cell carcinoma]]). | *[[Clear cell papillary renal cell tumour]] (previously [[clear cell papillary renal cell carcinoma]]). | ||
*[[ELOC-mutated renal cell carcinoma]]. | *[[ELOC-mutated renal cell carcinoma]]. | ||
*[[Xp11.2 translocation carcinoma]]. | *[[Xp11.2 translocation carcinoma]]. | ||
*[[Epithelioid angiomyolipoma]].{{fact}} | *[[Epithelioid angiomyolipoma]].{{fact}} | ||
| Line 18: | Line 17: | ||
*[[Melanotic Xp11 translocation renal cancer]]. | *[[Melanotic Xp11 translocation renal cancer]]. | ||
*[[Tuberous sclerosis-associated renal cell carcinoma]]. | *[[Tuberous sclerosis-associated renal cell carcinoma]]. | ||
*[[Renal cell carcinoma with fibromyomatous stroma]].<ref>{{cite journal |authors=Shah RB, Mehra R |title=Renal Cell Carcinoma Associated With TSC/MTOR Genomic Alterations: An Update on its Expanding Spectrum and an Approach to Clinicopathologic Work-up |journal=Adv Anat Pathol |volume= |issue= |pages= |date=October 2023 |pmid=37899532 |doi=10.1097/PAP.0000000000000419 |url=}}</ref><ref name=pmid36592877>{{cite journal |authors=Tjota MY, Sharma A, Wanjari P, Fitzpatrick C, Segal J, Antic T |title=TSC/MTOR mutated renal cell carcinoma with leiomyomatous stroma is a distinct entity: a comprehensive study of 12 cases |journal=Hum Pathol |volume=134 |issue= |pages=124–133 |date=April 2023 |pmid=36592877 |doi=10.1016/j.humpath.2022.12.015 |url=}}</ref> | |||
Benign things: | Benign things: | ||